Brain tumor patients may avoid radiation thanks to smart drug strategy
NCT ID NCT06974370
First seen May 30, 2026 · Last updated Jun 17, 2026 · Updated 2 times
Summary
This study is testing whether people with brain metastases (cancer that spread to the brain) can safely avoid radiation therapy if their cancer medication is working. About 45 adults with solid tumors, mostly non-small cell lung cancer, will start or continue systemic therapy (immunotherapy, targeted therapy, or chemo). After 4-8 weeks, a brain MRI will check if the tumors are shrinking or stable. If so, they skip radiation and continue monitoring. If tumors grow, they can still get standard radiation. The goal is to see how many people can avoid radiation for 6 months and to identify who benefits most.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES, ADULT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Vermont Medical Center
RECRUITINGBurlington, Vermont, 05401, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.